Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AcusensusASX:ACE -4.37%56 3-Year EBITDA Growth Rate is 0.00% as of Dec. 2025. GuruFocus rates ASX:ACE with a GF Score™ of 56/100 and a GF Value™ of A$1.50 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 2,072 Software companies, Acusensus ranks worse than 48262.5% on this metric.
During the past 12 months, Acusensus's average EBITDA Per Share Growth Rate was -335.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Acusensus 3-Year EBITDA Growth Rate Related Terms
ASX:ACE vs MSFT, ORCL, PLTR: 3-Year EBITDA Growth Rate Comparison
For the Software - Infrastructure subindustry, Acusensus's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acusensus 3-Year EBITDA Growth Rate vs Software Industry
For the Software industry and Technology sector, Acusensus's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Acusensus's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Acusensus (ASX:ACE) has a 3-Year EBITDA Growth Rate of 0.00% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Acusensus and its competitors. According to the industry distribution chart, Acusensus ranks #999999 out of 2072 companies in the Software industry.
Is Acusensus' 3-Year EBITDA Growth Rate too high?
Acusensus' current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Acusensus ranks #999999 out of 2072 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Acusensus has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Acusensus' 3-Year EBITDA Growth Rate compare to MSFT and ORCL?
According to the Software industry distribution chart, Acusensus ranks #999999 out of 2072 companies for 3-Year EBITDA Growth Rate. This places Acusensus in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 12.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Software company?
The median 3-Year EBITDA Growth Rate among Software companies is 12.40, based on 2,072 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Acusensus and its competitors. For the Software industry, the median 3-Year EBITDA Growth Rate is 12.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acusensus's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusensus stock overvalued right now?
Based on GuruFocus' analysis, Acusensus (ASX:ACE) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.50, compared to a current price of A$0.99 — trading 34.3% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Acusensus' overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Acusensus (ASX:ACE), the current 3-Year EBITDA Growth Rate is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acusensus (ASX:ACE) Overvalued in 2026?
Based on GuruFocus' analysis, Acusensus stock appears to be undervalued.
The current stock price of A$0.99 is trading 34.3% below its estimated GF Value™ of A$1.50.
GuruFocus considers Acusensus to be Possible Value Trap.
Key valuation signals for ASX:ACE:
3-Year EBITDA Growth Rate: 0.00%
GF Value™: A$1.50 vs. price of A$0.99 (34.3% below fair value)
No single metric tells the full story. See the ASX:ACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acusensus Ltd is involved in developing and commercializing intelligent traffic solutions technology. Its 'Heads-Up' solution has been designed to give authorities a tool to address distraction and other illegal driver behavior, to drive behavioral change on the road network. It also provides Data security solutions. The company's main objective is to Pioneer intelligent solutions to tackle difficult societal challenges, reduce road trauma and save lives. Geographically the company generates the majority of its revenue from Australia.
56GF Score
Get the complete analysis for ASX:ACE
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ACE has been successfully added to your 
